Close

Sucampo Pharma (SCMP) Tops Q2 EPS by 2c

May 6, 2015 6:34 AM EDT

Sucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $29.5 million versus the consensus estimate of $30.19 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings